167 related articles for article (PubMed ID: 9242545)
1. Even individuals considered as long-term nonprogressors show biological signs of progression after 10 years of human immunodeficiency virus infection.
Lefrère JJ; Morand-Joubert L; Mariotti M; Bludau H; Burghoffer B; Petit JC; Roudot-Thoraval F
Blood; 1997 Aug; 90(3):1133-40. PubMed ID: 9242545
[TBL] [Abstract][Full Text] [Related]
2. Correlation between surrogate markers, viral load, and disease progression in HIV-1 infection.
Lafeuillade A; Tamalet C; Pellegrino P; de Micco P; Vignoli C; Quilichini R
J Acquir Immune Defic Syndr (1988); 1994 Oct; 7(10):1028-33. PubMed ID: 7916049
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
Fahey JL; Taylor JM; Detels R; Hofmann B; Melmed R; Nishanian P; Giorgi JV
N Engl J Med; 1990 Jan; 322(3):166-72. PubMed ID: 1967191
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection.
Dyer WB; Zaunders JJ; Yuan FF; Wang B; Learmont JC; Geczy AF; Saksena NK; McPhee DA; Gorry PR; Sullivan JS
Retrovirology; 2008 Dec; 5():112. PubMed ID: 19077215
[TBL] [Abstract][Full Text] [Related]
5. Predictors of progression in long-term nonprogressors. Australian Long-Term Nonprogressor Study Group.
Ashton LJ; Carr A; Cunningham PH; Roggensack M; McLean K; Law M; Robertson M; Cooper DA; Kaldor JM
AIDS Res Hum Retroviruses; 1998 Jan; 14(2):117-21. PubMed ID: 9462921
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion.
Mellors JW; Kingsley LA; Rinaldo CR; Todd JA; Hoo BS; Kokka RP; Gupta P
Ann Intern Med; 1995 Apr; 122(8):573-9. PubMed ID: 7887550
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
Messele T; Brouwer M; Girma M; Fontanet AL; Miedema F; Hamann D; Rinke de Wit TF
Clin Immunol; 2001 Feb; 98(2):212-9. PubMed ID: 11161977
[TBL] [Abstract][Full Text] [Related]
8. Serum HIV-1 RNA levels compared to soluble markers of immune activation to predict disease progression in HIV-1-infected individuals.
Zangerle R; Steinhuber S; Sarcletti M; Dierich MP; Wachter H; Fuchs D; Möst J
Int Arch Allergy Immunol; 1998 Jul; 116(3):228-39. PubMed ID: 9693271
[TBL] [Abstract][Full Text] [Related]
9. Immune activation markers and AIDS prognosis.
Osmond DH; Shiboski S; Bacchetti P; Winger EE; Moss AR
AIDS; 1991 May; 5(5):505-11. PubMed ID: 1677808
[TBL] [Abstract][Full Text] [Related]
10. Virologic and serologic markers of rapid progression to AIDS after HIV-1 seroconversion.
Farzadegan H; Henrard DR; Kleeberger CA; Schrager L; Kirby AJ; Saah AJ; Rinaldo CR; O'Gorman M; Detels R; Taylor E; Phair JP; Margolick JB
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Dec; 13(5):448-55. PubMed ID: 8970472
[TBL] [Abstract][Full Text] [Related]
11. Early markers of HIV infection and subclinical disease progression.
Dolan MJ; Lucey DR; Hendrix CW; Melcher GP; Spencer GA; Boswell RN
Vaccine; 1993; 11(5):548-51. PubMed ID: 8098175
[TBL] [Abstract][Full Text] [Related]
12. Comparable biological and molecular determinants in HIV type 1-infected long-term nonprogressors and recently infected individuals.
Balotta C; Bagnarelli P; Riva C; Valenza A; Antinori S; Colombo MC; Sampaolesi R; Violin M; de Pasquale MP; Moroni M; Clementi M; Galli M
AIDS Res Hum Retroviruses; 1997 Mar; 13(4):337-41. PubMed ID: 9071433
[TBL] [Abstract][Full Text] [Related]
13. Behaviour of different clinical, immunological and serological parameters observed in a group of HIV positive patients during a 12 month treatment period with zidovudine.
Crocchiolo PR; Lizioli A; Arcidiacono I; Cantaluppi P; Filippi C; Sobatti D; Bedarida G; D'Agostino F; Cambie G; Nardella ML
Boll Ist Sieroter Milan; 1990 Jun; 69(2):423-30. PubMed ID: 1983798
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of serum beta 2-microglobulin in HIV infection.
Krämer A; Goedert JJ; Wachter H; Fuchs D
Lancet; 1992 Aug; 340(8815):371. PubMed ID: 1379663
[No Abstract] [Full Text] [Related]
15. Prospective longitudinal analysis of viral load and surrogate markers in relation to clinical progression in HIV type 1-infected persons.
Bruisten SM; Frissen PH; Van Swieten P; Harrigan PR; Kinghorn I; Larder B; Weigel HM; De Vries E; Regez RM; Henrichs JH; Koot M; Huisman JG
AIDS Res Hum Retroviruses; 1997 Mar; 13(4):327-35. PubMed ID: 9071432
[TBL] [Abstract][Full Text] [Related]
16. Immunologic markers of progression to acquired immunodeficiency syndrome are time-dependent and illness-specific.
Krämer A; Biggar RJ; Hampl H; Friedman RM; Fuchs D; Wachter H; Goedert JJ
Am J Epidemiol; 1992 Jul; 136(1):71-80. PubMed ID: 1384311
[TBL] [Abstract][Full Text] [Related]
17. Effector HIV-specific cytotoxic T-lymphocyte activity in long-term nonprogressors: associations with viral replication and progression.
Keoshkerian E; Ashton LJ; Smith DG; Ziegler JB; Kaldor JM; Cooper DA; Stewart GJ; Ffrench RA
J Med Virol; 2003 Dec; 71(4):483-91. PubMed ID: 14556259
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal quantification of human immunodeficiency virus type 1 DNA and RNA in long-term nonprogressors.
Broström C; Visco-Comandini U; Yun Z; Sönnerborg A
J Infect Dis; 1999 Jun; 179(6):1542-8. PubMed ID: 10228079
[TBL] [Abstract][Full Text] [Related]
19. Early and late HIV-1 RNA level and its association with other markers and disease progression in long-term AIDS-free homosexual men.
Spijkerman IJ; Prins M; Goudsmit J; Veugelers PJ; Coutinho RA; Miedema F; de Wolf F
AIDS; 1997 Sep; 11(11):1383-8. PubMed ID: 9302449
[TBL] [Abstract][Full Text] [Related]
20. Clinical and laboratory predictors of survival in Gambian patients with symptomatic HIV-1 or HIV-2 infection.
Whittle H; Egboga A; Todd J; Corrah T; Wilkins A; Demba E; Morgan G; Rolfe M; Berry N; Tedder R
AIDS; 1992 Jul; 6(7):685-9. PubMed ID: 1354448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
